Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas
Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This study is designed as a multi-centre randomized, open label trial to compare the safety
and efficacy of a high dose primaquine (PQ) treatment in G6PD normal patients with P.
falciparum to reduce the risk of subsequent P. vivax episodes to current standard practice of
providing only schizontocidal treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Menzies School of Health Research
Collaborators:
Addis Ababa University Arba Minch University Arba Minch University, Ethiopia International Centre for Diarrhoeal Disease Research, Bangladesh Tribhuvan University, Nepal